How big is the United States Heparin Market?

The United States Heparin Market size is expected to reach USD 1.33 billion in 2024 and grow at a CAGR of 6.54% to reach USD 1.82 billion by 2029. Read More

What is the current United States Heparin Market size?

In 2024, the United States Heparin Market size is expected to reach USD 1.33 billion. Read More

Who are the key players in United States Heparin Market?

Pfizer Inc., B Braun Melsungen AG, Baxter International Inc., Sagent Pharmaceuticals and Mylan N.V. are the major companies operating in the United States Heparin Market. Read More

What years does this United States Heparin Market cover, and what was the market size in 2023?

In 2023, the United States Heparin Market size was estimated at USD 1.25 billion. The report covers the United States Heparin Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the United States Heparin Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

United States Heparin Market Report | Industry Analysis, Size & Forecast

United States Heparin Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The United States Heparin Market is segmented by Product(Unfractionated Heparin, Low Molecular Weight Heparin(LMWH) and Ultra-Low Molecular Weight Heparin(ULMWH)), Source (Bovine, Porcine), and Application (Atrial Fibrillation and Heart Attack, Stroke, Deep Vein Thrombosis (DVT) and Others). The Market Size and Forecast are Provided in Terms of Value (In USD Million) for the Above Segments.

United States Heparin Industry Overview

The United States Heparin market is a consolidated market, owing to the presence of a few major players in the market. The major market players, such as Baxter International Inc., Pfizer Inc., Sagent Pharmaceuticals, Mylan N.V., Bayer AG hold a significant market share in the country.